Publication | Closed Access

First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: Preliminary retrospective study with a seven year follow-up

Novel ProtocolDermatologyLine TreatmentMedicinePemphigus Vulgaris